Unusual 11 Mid-Day Movers 07/18: (SUPN) (GALE) (APH) Higher; (ROVI) (WHX) (BAMM) Lower
Tweet Send to a Friend
Get Alerts ROVI Hot Sheet
Up)
Trade ROVI Now!
Rovi Corporation (Nasdaq: ROVI) 40.7% LOWER; sees Q2 EPS of $0.35-$0.38, vs $0.57. Revenues $158-$179 million, versus the consensus of $182.6 million. The stock was downgraded at BMO, Piper Jaffray, JPMorgan, Barrington and Cowen this morning.
Whiting USA Trust I (NYSE: WHX) 26.5% LOWER; shares continuing lower after failing to push over the 50-day simple moving average a number of times yesterday. The stock fell more than 9 percent yesterday. Shares plunged through support at $14 this morning.
Supernus Pharma (Nasdaq: SUPN) 26.2% HIGHER; gapped over resistance at $11, quickly charged through the $12 level, and has now moved over $13. Volume is very heavy Wednesday.
Galena Biopharma, Inc. (Nasdaq: GALE) 22.8% HIGHER; was issued a key patent, originally allowed in March 2012, from the USPTO covering the use of its product candidate, NeuVax™, a HER2/neu peptide vaccine, for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC levels of 1+ or 2+ and a FISH rating of less than 2.0.
Books-A-Million, Inc. (Nasdaq: BAMM) 19.9% LOWER; announced that the Anderson family has withdrawn the previously announced non-binding proposal made on April 28, 2012, to acquire all of the outstanding publicly-held shares of the common stock of the Company for $3.05 per share. After discussing the proposal with the Special Committee of the Company’s Board of Directors and its advisors, the Anderson family has decided not to pursue the proposed acquisition at this time.
New Oriental Education (NYSE: EDU) 19.0% LOWER; downgraded at Jefferies and Oppenheimer today.
Harte-Hanks, Inc. (NYSE: HHS) 16.8% LOWER; sees Q2 sales of $195-$205 million and EPS of 10-12 cents. The Street is looking for revs of $208.9 million and EPS of $0.16. Sees a Q2 non-cash pre-tax charge of $150-$177 million. Click here to see the full report.
Amphenol, Inc. (NYSE: APH) 15.9% HIGHER; reported Q2 EPS of $0.79, $0.05 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion. Sees Q3 sales of $1.08-$1.1 billion, which compares to the Street estimate of $1.06 billion. Sees EPS of 87-90c, vs. the consensus of 85c.
VIVUS, Inc. (Nasdaq: VVUS) 14.1% HIGHER; the FDA approved VIVUS's weight-loss drug Qsymia (Qnexa) as added reduced-calorie diet pill, according to Bloomberg headlines.
Digital Domain Media Group (NYSE: DDMG) 13.7% HIGHER; Digital Domain and Prime Focus World NV have signed an agreement whereby Digital Domain Media Group (DDMG) will license its 3D conversion technology to Prime Focus World. The agreement settles and terminates the patent infringement litigation action filed by DDMG against Prime Focus World in 2011. Under the agreement DDMG and Prime Focus World will collaborate on visual effects and 2D-to-3D conversion services work for feature films.
AAR Corp. (NYSE: AIR) 12.5% HIGHER; reported Q4 EPS of $0.45, $0.01 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $563.3 million versus the consensus estimate of $562.3 million. AAR Corp. reaffirmed FY2012 guidance.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Whiting USA Trust I (NYSE: WHX) 26.5% LOWER; shares continuing lower after failing to push over the 50-day simple moving average a number of times yesterday. The stock fell more than 9 percent yesterday. Shares plunged through support at $14 this morning.
Supernus Pharma (Nasdaq: SUPN) 26.2% HIGHER; gapped over resistance at $11, quickly charged through the $12 level, and has now moved over $13. Volume is very heavy Wednesday.
Galena Biopharma, Inc. (Nasdaq: GALE) 22.8% HIGHER; was issued a key patent, originally allowed in March 2012, from the USPTO covering the use of its product candidate, NeuVax™, a HER2/neu peptide vaccine, for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC levels of 1+ or 2+ and a FISH rating of less than 2.0.
Books-A-Million, Inc. (Nasdaq: BAMM) 19.9% LOWER; announced that the Anderson family has withdrawn the previously announced non-binding proposal made on April 28, 2012, to acquire all of the outstanding publicly-held shares of the common stock of the Company for $3.05 per share. After discussing the proposal with the Special Committee of the Company’s Board of Directors and its advisors, the Anderson family has decided not to pursue the proposed acquisition at this time.
New Oriental Education (NYSE: EDU) 19.0% LOWER; downgraded at Jefferies and Oppenheimer today.
Harte-Hanks, Inc. (NYSE: HHS) 16.8% LOWER; sees Q2 sales of $195-$205 million and EPS of 10-12 cents. The Street is looking for revs of $208.9 million and EPS of $0.16. Sees a Q2 non-cash pre-tax charge of $150-$177 million. Click here to see the full report.
Amphenol, Inc. (NYSE: APH) 15.9% HIGHER; reported Q2 EPS of $0.79, $0.05 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion. Sees Q3 sales of $1.08-$1.1 billion, which compares to the Street estimate of $1.06 billion. Sees EPS of 87-90c, vs. the consensus of 85c.
VIVUS, Inc. (Nasdaq: VVUS) 14.1% HIGHER; the FDA approved VIVUS's weight-loss drug Qsymia (Qnexa) as added reduced-calorie diet pill, according to Bloomberg headlines.
Digital Domain Media Group (NYSE: DDMG) 13.7% HIGHER; Digital Domain and Prime Focus World NV have signed an agreement whereby Digital Domain Media Group (DDMG) will license its 3D conversion technology to Prime Focus World. The agreement settles and terminates the patent infringement litigation action filed by DDMG against Prime Focus World in 2011. Under the agreement DDMG and Prime Focus World will collaborate on visual effects and 2D-to-3D conversion services work for feature films.
AAR Corp. (NYSE: AIR) 12.5% HIGHER; reported Q4 EPS of $0.45, $0.01 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $563.3 million versus the consensus estimate of $562.3 million. AAR Corp. reaffirmed FY2012 guidance.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Piper Jaffray, JPMorgan, Jefferies & Co, Cowen & Co, Unusual 11 Mid-Day Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
